PT140.S2.Q8

PrepTest 140 - Section 2 - Question 8

Show summary

Mark: The decongestant drug Zokaz was discontinued by its manufacturer because long-term studies revealed that it increased the risk of heart attack. ████████ ███████ █████████████ █████ ██ ███████████ ███ ████ █████████████ █████████ ██ ██████ ██ ███████ ████████ ████ █████████ ███ ████ ██ █████ ███████

██████ ███ ████████████ ███████ ██ ███ ███ █████ ██ ████ ████ ███ ████ █████████████ ██████████ ███ █████ ████ ███ █████████ ███████████ ███ ███ █████ ████████ ████ █████████ ████ ████████

Summarize Argument: Counter-Position

Kathy concludes that Zokaz and Qualzan probably have different side effects. She supports this by saying that, although they work the same way to relieve congestion, the two drugs are chemically different.

Describe Method of Reasoning

Kathy counters Mark’s argument by pointing out a relevant dissimilarity between that the two things that he’s analogizing. By showing that Zokaz and Qualzan are chemically different, even though they relieve congestion in the same way, Kathy undermines Mark’s conclusion that Qualzan increases the risk of heart attack like Zokaz.

Show answer
8.

Which one of the following ██ █ █████████ ██ █████████ ████ ██ ███████ ████████ ██ █████

a

using a product's ███████ ██████ ██ ██████ ██ ████████ ████ ███ ███████ ██ ███ ██████ ██ █ ██████████ ██████ ███████

b

attempting to discredit ██ ████████ ██ █████████ ██ ██ ███████ █████████ ██████ ████████ ████ ██ █████████ ████████

c

arguing against a ██████████ ██ ███████ █████████ █████ ███ ████████ ██ ██████████ ███████ █████ ██ ███████ ██ ████ ██████████

d

attempting to undermine ██ ████████ ██ ███████ ████ ██ ██ ████████████ ████ █ ███████████ █████████ ██ ████████

e

challenging an argument ████ ███████ ██ ████████ ██ █ █████████████ ███████ ███ ██████ █████ ████████

Confirm action

Are you sure?